LEUCEMIE AIGUE MYELOBLASTIQUE PDF

Acute lymphoblastic leukemias among children in Ouagadougou Burkina Faso : the results of treatment according to the protocol of the Franco-African Pediatric Oncology Group Introduction: acute lymphoblastic leukemia ALL is being diagnosed in an increasing number of children in our Department. In developing countries, few studies focus on acute leukemias in children. This study aimed to investigate the clinical, biological, therapeutic and evolutionary features of ALL in children.

Author:Kazrataxe Nibar
Country:Uganda
Language:English (Spanish)
Genre:Automotive
Published (Last):14 December 2016
Pages:109
PDF File Size:6.38 Mb
ePub File Size:9.99 Mb
ISBN:572-2-39829-412-7
Downloads:8590
Price:Free* [*Free Regsitration Required]
Uploader:JoJojin



The upper age limit for a pediatric-inspired therapy in younger adults with Ph-negative acute lymphoblastic leukemia? Analysis of the Graall Study. Blood ; 22 Blood Cancer J ;6 12 :e Rituximab in B-lineage adult acute lymphoblastic leukemia. N Engl J Med ; 11 Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

J Clin Oncol ;29 18 Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia. Haematologica ; 4 :ee Long-term outcomes after blinatumomab treatment: follow-up of a phase 2 study in patients with minimal residual disease positive B-cell precursor acute lymphoblastic leukemia.

Blood ; Phase II trial of the anti-CD19 bispecific T cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia. J Clin Oncol ;32 36 Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

Lancet Oncol ;16 1 Blinatumomab versus chemotherapy for advanced acute lymphoblastic leukemia. N Engl J Med ; 9 Blood ; 24 Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med ; 16 Efficacy and toxicity management of z CAR T cell therapy in B cell acute lymphoblastic leukemia. Sci Transl Med ;6 : ra Lancet ; : J Clin Invest ; 9 Infusion of donor-derived CDredirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study.

Blood ; 17 J Clin Invest ; 6 Cancer Discov ;5 12 Topp et al. Martinelli et al. Kantarjian et al. Maude et al. Davila et al. Cruz et al. Lee et al. Kebriaei et al. Turtle et al. Ils ne contiennent aucune information sensible. En savoir plus. Merci de saisir votre e-mail. Inscrivez-vous gratuitement. Cabannes-Hamy, N. Blood ; 26 Annuler Confirmer. Merci de choisir le cas qui vous concerne. Je suis membre des sites Edimark. Merci de saisir votre adresse email. Annuler envoyer. Se souvenir de moi.

Retour au site.

BENTCHING PDF

Leucémie aiguë lymphoblastique

The upper age limit for a pediatric-inspired therapy in younger adults with Ph-negative acute lymphoblastic leukemia? Analysis of the Graall Study. Blood ; 22 Blood Cancer J ;6 12 :e Rituximab in B-lineage adult acute lymphoblastic leukemia. N Engl J Med ; 11

FS5KM DATASHEET PDF

Immunothérapie dans les leucémies aiguës lymphoblastiques : anticorps bispécifiques et CAR-T cells

Celles-ci se nomment chlorome ou sarcome granulocytaire. Les LLA de mauvais pronostic comprennent les translocations t 9;22 chromosome de Philadelphie , t 1;19 et 11 q23 translocation entre le chromosome 11 et plusieurs autres chromosomes. Aapro, P. Rev Med Suisse ; volume 4. Tableau 1.

Related Articles